Vonoprazan is a potassium-competitive acid blocker (PCAB) used to treat acid-related disorders by strongly reducing stomach acid production. Key uses include treating gastroesophageal reflux disease (GERD), erosive esophagitis, gastric/duodenal ulcers, and H. pylori eradication (when combined with antibiotics). It offers faster, more durable relief than traditional PPIs.